Radiopharmaceutical Laboratory Services (RLS) MAMC
ID: W81K0226QA015Type: Combined Synopsis/Solicitation
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE ARMYW40M MRCO PACIFICFORT SHAFTER, HI, 96858-5098, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

No Set aside used (NONE)
Timeline
    Description

    The Department of Defense, through the Medical Readiness Contracting Office Pacific, is seeking qualified vendors to provide Radiopharmaceutical Laboratory Services for the Madigan Army Medical Center (MAMC) in Tacoma, Washington. The procurement includes a range of radiopharmaceuticals such as Technetium (Tc99m), Iodine (I-123, I-131), and related medical supplies, with a focus on FDA-approved materials and compliance with Joint Commission and USP 825 standards. These services are critical for supporting medical operations at the facility, ensuring timely access to essential radiopharmaceuticals for patient care. Interested vendors must submit their quotes by 10:00 AM PDT on January 15, 2026, to the primary contacts, Cindy Means and Scott Barr, with deliveries scheduled from January 31, 2026, to January 30, 2031.

    Point(s) of Contact
    Files
    Title
    Posted
    The document is a federal solicitation (W81K0226QA015) for Women-Owned Small Businesses (WOSB) to provide radiopharmaceuticals and related services to the AMC Madigan Lewis - MM Fitzsimmons at Joint Base Lewis McChord, WA. The solicitation, issued by W81K02 MRCO Pacific, seeks various Tc99m, I-123, I-131, In-111, Heparin, and Kinevac/Sincalide products, along with delivery services, pharmacist call-outs, and priority freight, all under firm-fixed-price arrangements. Key requirements include FDA-approved materials, Joint Commission accreditation, USP 825 compliance, 24/7 customer support, and urgent/STAT delivery capabilities for radioactive materials. Deliveries are scheduled from January 31, 2026, to January 30, 2031, with inspection and acceptance at the destination. The contract incorporates various FAR and DFARS clauses, including those for unique item identification and Wide Area WorkFlow payment instructions, underscoring stringent federal procurement regulations.
    This Request for Quotation (RFQ) W81K0226QA015 is a combined synopsis/solicitation for commercial radiopharmaceuticals, issued by the Medical Readiness Contracting Office – Pacific. The government intends to award a firm-fixed-price purchase order to the lowest-priced responsible bidder, evaluating quotations without discussions unless deemed necessary. Offerors must provide all submittals to be technically acceptable and complete the line-item pricing structure, including all applicable non-exempt taxes. The estimated ordering period is from January 31, 2026, to January 30, 2031, with delivery to Madigan Army Medical Center, Joint Base Lewis McChord, Washington. The NAICS code is 325412 (Pharmaceutical Preparation and Manufacturing) and the PSC is 6505 (Drugs and Biologics). Quotes are due by 10:00 AM PDT on Thursday, January 15, 2026, and should be submitted via email to Cindy Means and Scott Barr, including a cover page with Offeror details and POCs. Offerors registered in SAM with current representations and certifications do not need to complete FAR Provision 52.212-3.
    This government solicitation, W81K0226QA0150001, issued by the MEDICAL READINESS CONTR OFC PACIFIC, is an Request for Quote (RFQ) for Radiopharmaceuticals for Madigan Army Medical Center (MAMC). The solicitation is set aside for Women-Owned Small Businesses (WOSB) and Economically Disadvantaged Women-Owned Small Businesses (EDWOSB). Key requirements include the provision of various Tc99m, I-123, and I-131 radiopharmaceuticals, along with other related medical supplies and services such as Heparin and WBC collection kits. The contractor must use FDA-approved materials, be Joint Commission accredited, comply with USP 825 standards, and provide 24/7 customer support with urgent and STAT delivery capabilities. All items will be inspected and accepted at AMC Madigan Lewis – MM Fitzsimmons. Deliveries are scheduled from January 31, 2026, to January 30, 2031, with the contractor responsible for transportation costs to the destination. The document also incorporates several FAR and DFARS clauses, including specific requirements for Item Unique Identification and Wide Area WorkFlow payment instructions.
    This document, Amendment/Modification Number W81K0226QA0150001, issued by W40M MRCO PACIFIC on January 7, 2026, amends a solicitation or modifies a contract. The amendment primarily focuses on updating quantities and descriptions for various medical supplies and services (CLINs 0001-0032). Key changes include significant increases and decreases in quantities for different types of Technetium (Tc99m) and Iodine (I-123, I-131, In-111) based radiopharmaceuticals and related kits. For example, quantities for Tc99m Myoview and Sestamibi saw substantial increases, while others like Tc99m Filtered Sulfur Colloid and I-131 Tx cap ea. additional mCi experienced significant decreases or changes in description. Additionally, the delivery information for all modified CLINs specifies that the items are to be delivered to AMC MADIGAN LEWIS - MM (HT0864) with a delivery period from January 31, 2026, to January 30, 2031.
    Lifecycle
    Title
    Type
    Combined Synopsis/Solicitation
    Similar Opportunities
    Loading similar opportunities...